Clin2
NCT07445815Possibly a fitNot yet recruiting

Testing a new rabies antibody in healthy adults

Rabies (Healthy Volunteers)

Treatments studied

Part of Infections clinical trials.

This trial tests a new lab-made antibody to prevent rabies after exposure. It is for healthy volunteers who have not gotten a rabies vaccine or been exposed to rabies before.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
200 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • You are generally healthy (no major diseases like autoimmune or chronic hepatitis).
  • You have never received a rabies vaccine or been exposed to rabies (with known or suspected bite, scratch, or lick).
  • You are not allergic to the study drug or similar products, and have no history of severe allergies.
  • You are willing to use effective birth control for the study period and not become pregnant or donate sperm.
  • You have not participated in another drug or device trial in the past 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07416110Not yet recruiting· Phase 3
Rabies vaccine lot consistency trial for healthy adults

This trial tests whether different batches of an experimental rabies vaccine work the same way. It is for healthy adults aged 18 to 45 who have not been exposed to rabies or received rabies treatment before.

Deyang
NCT07055893Not yet recruiting· Phase 3
Rabies vaccine trial for people who may need post-exposure shots

This trial tests a rabies vaccine to see if it works well and is safe when given after a potential rabies exposure. It may help people who need protection after an animal bite.

Rawalpindi
NCT07455318Not yet recruiting· Phase 3
Testing rabies booster shots 5 years after first vaccination

This trial checks how well a rabies booster shot works in healthy adults who had rabies pre-exposure shots at least 5 years ago. It compares three different booster schedules to see which one best protects against rabies.

Antwerp
NCT07149454Enrolling by invitation· Phase 1
Testing a new antibody to prevent tetanus

This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.

Lanzhou, Gansu
NCT06548139Not yet recruiting· Phase 2
Rabies antibody and vaccine combo for healthy adults

This trial tests a new rabies antibody combined with a vaccine to see if it can prevent rabies. It is for healthy adults who have not been exposed to rabies before.

Kunming, Yunnan
NCT07028801Not yet recruiting· Phase 3
Testing a new rabies vaccine for people

This trial tests a new freeze-dried rabies vaccine made from human cells. It is for people who may need protection against rabies after a possible exposure, and the study will compare it to standard rabies vaccines.

Zhengzhou, Henan

Hear when a new Rabies (Healthy Volunteers) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.